Sign in

CIK 0001570562

  • Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461385614
Phone
+1 949-284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
  1. 4 Open-market buy Director bought 20,000 shares at $9.45 ($189,000)
  2. 4 Planned sale See Remarks sold 3,385 shares at $9.87 ($33,397)
  3. 4 Planned sale Chief Financial Officer sold 6,494 shares at $10.02 ($65,070)
  4. 4 Planned sale See Remarks sold 15,787 shares at $9.87 ($155,756)
  5. 4 Planned sale See Remarks sold 6,251 shares at $12.40 ($77,512)
  6. 4 Planned sale See Remarks sold 27,904 shares at $13.26 ($369,868)
  7. 4 Planned sale Chief Financial Officer sold 8,996 shares at $13.26 ($119,243)
  8. 4 Planned sale Chief Marketing Officer sold 4,536 shares at $13.26 ($60,125)
  9. 4 Planned sale See Remarks sold 103,376 shares at $13.26 ($1,370,249)
  10. 4 Open-market sale Director sold 12,888 shares at $12.99 ($167,465)
  11. 4 Grant or award Chief Marketing Officer acquired 17,832 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 35,663 shares (grant or award)
  13. 4 Grant or award See Remarks acquired 95,399 shares (grant or award)
  14. 4 Grant or award See Remarks acquired 23,776 shares (grant or award)
  15. 4 Grant or award Director acquired 7,364 shares (grant or award)
  16. 4 Grant or award Director acquired 7,364 shares (grant or award)
  17. 4 Grant or award Director acquired 7,364 shares (grant or award)
  18. 4 Grant or award Director acquired 7,364 shares (grant or award)
  19. 4 Grant or award Director acquired 7,364 shares (grant or award)
  20. 4 Grant or award Director acquired 7,364 shares (grant or award)

Page 2 of 13 · 252 filings